10.1 Intervention, Referral & Follow-Up
Key Takeaways
- Intervention and/or referral is the fourth APhA/NACDS core element: the pharmacist or qualified provider acts on medication-related problems with the patient and/or other clinicians.
- Referrals send the patient to another professional or setting when the needed action is outside the MTM provider’s scope or when specialty care is required.
- Documentation and follow-up closes the loop—recording what was done and verifying outcomes, adherence to the MAP, and unresolved problems on a planned timeline.
- Technicians track pending interventions, schedule follow-ups, log outreach attempts, and escalate non-responses; they do not independently decide therapy changes or clinical referrals.
- CMS Part D MTM programs must offer interventions for both beneficiaries and prescribers, and must perform quarterly TMRs with follow-up interventions when necessary.
10.1 Intervention, Referral & Follow-Up
Quick Answer: After the MTR finds problems and the PMR/MAP are updated, the team must act (intervention and/or referral) and then prove and recheck (documentation and follow-up). Technicians keep the queue moving—tracking messages, due dates, and outreach—while pharmacists own clinical decisions.
Chapter 9 covered the first three APhA/NACDS core elements (MTR, PMR, MAP). This section finishes the model: intervention and/or referral (element 4) and the follow-up half of documentation and follow-up (element 5). Domain 3 (MTM Administration & Management, 24%) tests whether you know that identifying a problem is not enough—someone must intervene, refer when needed, document the work, and follow up until the issue is resolved or deliberately closed.
Why These Elements Exist
An MTR that discovers a dangerous NSAID in heart failure is useless if nobody contacts the prescriber, nobody updates the patient’s MAP, and nobody calls back to confirm the NSAID stopped. The APhA/NACDS model treats action and continuity as formal core elements—not optional extras after “the consult.”
In Medicare Part D MTM, CMS reinforces the same idea. Under 42 CFR § 423.153(d), Part D sponsors must offer a minimum level of MTM services that includes interventions for both beneficiaries and prescribers and quarterly targeted medication reviews (TMRs) with follow-up interventions when necessary. The clinical model and the CMS program rules both expect a closed loop.
Intervention: Acting on Medication-Related Problems
An intervention is a deliberate action taken to resolve or mitigate a medication-related problem (MRP). Interventions may be directed to:
- The patient (education, adherence tools, self-monitoring, clarification of instructions)
- The prescriber or care team (recommend dose change, discontinue a drug, add monitoring, switch therapy)
- The pharmacy/dispensing process (clarifying directions, synchronizing fills, resolving access barriers—within scope)
| Intervention type | Typical trigger | Who decides | Example |
|---|---|---|---|
| Patient education / counseling | Knowledge gap, technique error, fear of side effects | Pharmacist (tech may schedule and prepare materials) | Teach-back on inhaler technique; explain why a statin is continued after mild myalgia workup |
| Adherence support | Missed doses, late refills, cost barriers | Pharmacist designs plan; tech implements logistics | Pill organizer + reminder; 90-day supply request; manufacturer assistance referral |
| Prescriber consult | Needs order change or clinical judgment beyond OTC advice | Pharmacist | Fax/secure message recommending stop of duplicate ACE inhibitor |
| Monitoring recommendation | Labs/vitals needed to assess safety/effectiveness | Pharmacist | Request BMP after starting an ACE inhibitor; BP log review |
| Therapy clarification | Ambiguous directions, conflicting labels | Pharmacist with tech fact-finding | Confirm “take with food” timing after discharge |
Hard boundary: Technicians gather facts, draft message templates for pharmacist review, transmit pharmacist-approved communications, and log statuses. Technicians do not independently recommend stopping a prescription drug, changing a dose, or diagnosing the clinical cause of an adverse effect.
Referral: When Another Professional Must Own the Next Step
A referral transfers responsibility for a needed action to another clinician or setting. Referral is appropriate when:
- The problem requires medical diagnosis or prescribing outside pharmacy collaborative practice authority
- Specialty care is needed (e.g., anticoagulation clinic, endocrinology, behavioral health, pain management)
- Urgent/emergent symptoms suggest the patient needs immediate medical evaluation, not a routine MTM call-back
- Care coordination (home health, case management, social work) is required to address social determinants that block safe medication use
| Situation | Prefer intervention in-pharmacy | Prefer referral |
|---|---|---|
| Patient uses OTC NSAID with heart failure; willing to stop | Pharmacist educates; MAP: stop ibuprofen; acetaminophen as directed; notify PCP | If chest pain/edema worsening → urgent medical evaluation |
| Suspected new drug allergy with rash + breathing difficulty | Supportive documentation and triage | Emergency/urgent care referral immediately |
| Persistent uncontrolled A1C despite adherence coaching | Pharmacist recommends regimen review to PCP | Endocrinology referral if plan/pharmacist triage indicates |
| Patient cannot afford insulin and needs benefits navigation | Pharmacy assistance workflows | Social work / plan case management referral |
Intervention and referral are often paired: the pharmacist intervenes with a recommendation and refers the patient to the clinic for evaluation. The MAP should tell the patient what they can do while waiting; the clinical note should show what the care team was asked to do.
Documentation and Follow-Up as One Core Element
In the APhA/NACDS sequence, element 5 is documentation and follow-up—not “documentation or follow-up.” Documentation without follow-up leaves interventions unfinished. Follow-up without documentation cannot be audited, billed, or safely continued by another team member.
Follow-up purposes:
- Confirm the patient completed MAP actions
- Confirm the prescriber responded (accepted, modified, or declined recommendations)
- Reassess symptoms, adherence, labs, or vitals tied to the MRP
- Detect new problems created by the change
- Update the PMR/MAP and close or escalate open issues
Typical timelines (program-dependent, clinically driven):
| Follow-up focus | Common timing | Tech support role |
|---|---|---|
| High-risk safety change (e.g., stop interacting drug) | Days to ~1–2 weeks | Schedule call; log attempts; escalate no-answer |
| Adherence plan after CMR | ~1–2 weeks | Structured outreach checklist; document barriers |
| Await lab/clinic visit | Tied to appointment date | Reminder before visit; capture results when available |
| Quarterly TMR-driven issue | Per TMR cycle + anytime when necessary | Queue TMR alerts; track “follow-up needed” flags |
CMS expects quarterly TMRs with follow-up interventions when necessary. A TMR is focused on specific actual or potential MRPs; it is distinct from a full annual CMR, but it still can generate beneficiary or prescriber follow-up actions that must be tracked.
Technician Support: Tracking Follow-Ups Like a Clinical Operations Engine
High-performing MTM teams treat open interventions as a work queue, not a memory exercise. Technicians are often the people who keep that queue honest.
Practical tracking tasks
- Maintain a pending intervention log (patient ID, MRP summary code, date sent, channel, responsible pharmacist, due date, status)
- Schedule follow-up encounters and reminder tasks in the MTM platform
- Document outreach attempts (date/time, method, outcome: reached / left message / wrong number / declined)
- Pull refill history, claim status, and prior notes so the pharmacist’s follow-up call is informed
- Flag overdue items for pharmacist triage daily or per site SOP
- After resolution, help update PMR/MAP drafts and ensure the chart shows closure reason
Status vocabulary that keeps teams aligned
| Status | Meaning | Next action |
|---|---|---|
| Drafted | Message/note prepared, not sent | Pharmacist review/send |
| Sent – awaiting response | Prescriber/patient contacted | Follow-up on due date |
| Patient reached – pending behavior change | Agreed to MAP action | Confirm completion at follow-up |
| Accepted / completed | Recommendation implemented or MAP done | Update docs; close or monitor |
| Declined / deferred | Patient or prescriber declined | Document rationale; escalate if safety-critical |
| Unable to reach | Exhausted outreach attempts per SOP | Alternate channel; escalate; document |
Scenario — Closing the loop
Ms. Patel’s CMR finds duplicate therapy: two pharmacies filling different ACE inhibitors. The pharmacist sends a prescriber intervention recommending consolidation. The technician:
- Logs the fax/secure message with date and attachment ID
- Sets a 5-business-day follow-up task
- On day 5, checks for reply; if none, initiates a second contact per SOP and notifies the pharmacist
- When the clinic accepts the change, helps update the PMR, confirms the discontinued Rx is inactivated, and schedules a 2-week adherence check
- Documents each step so an auditor can reconstruct the timeline
Without technician tracking, “we faxed them” becomes a black hole—exactly what Domain 3 questions punish.
Linking Interventions to MAP and Patient Experience
Patient-facing MAP items and clinician-facing interventions must stay consistent:
- If the pharmacist recommends stopping a drug pending clinic approval, the MAP should not instruct the patient to stop unilaterally unless that instruction was clinically approved and clearly communicated
- If the intervention is educational only, the MAP can carry the patient actions immediately
- Follow-up questions should reference the MAP (“Were you able to set the evening alarm for metformin?”) rather than vague “How are your meds?”
Effective follow-up uses open-ended questions and teach-back, not a one-way reminder blast. Passive mass texts alone are weak substitutes for structured MTM follow-up when the goal is to evaluate barriers and outcomes.
Exam Traps
- Treating “identified MRP” as complete without intervention/referral
- Confusing referral (hand off care) with prescriber intervention (recommend a change while remaining in the MTM episode)
- Assuming technicians may close clinical recommendations without pharmacist oversight
- Skipping follow-up after a CMR adherence finding
- Believing a declined CMR ends all MTM obligations (CMS still expects other required services such as TMRs and interventions—covered further in Chapter 11)
Role Clarity Checklist Before You Move On
| Question | If “yes,” owner is usually… |
|---|---|
| Does therapy need to change by prescription? | Pharmacist intervention ± referral to prescriber |
| Can the patient act safely today with education/tools? | Pharmacist-directed patient intervention + MAP |
| Is the patient unstable or emergent? | Referral to urgent/emergent care |
| Who ensures the fax gets a response by Friday? | Technician tracking + pharmacist escalation |
| Who decides the clinical recommendation text? | Pharmacist / qualified provider |
Master this division of labor and you will answer both workflow and patient-safety items in Domain 3 with confidence.
Which statement best describes the APhA/NACDS core element “intervention and/or referral”?
A CMR finds the patient started daily ibuprofen while taking apixaban. The pharmacist sends a secure message to the prescriber recommending discontinuation of the NSAID and safer pain options. What is the technician’s most appropriate next responsibility?
When is referral the most appropriate path rather than handling the issue solely as an in-pharmacy patient education intervention?
One to two weeks after a CMR identified nonadherence and created MAP actions, which follow-up approach best matches MTM core-element expectations?